Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.730
-0.020 (-1.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edesa Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 20, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 6 | 14 | 13 | 14 | 98 | 78 | |
| Market Cap Growth | 8.40% | 8.40% | -6.42% | -85.44% | 26.16% | 65.89% | |
| Enterprise Value | 5 | 12 | 7 | 1 | 90 | 75 | |
| Last Close Price | 1.73 | 4.45 | 4.42 | 6.45 | 51.66 | 56.49 | |
| Forward PE | - | - | - | 56.67 | - | - | |
| PS Ratio | - | - | - | - | - | 235.84 | |
| PB Ratio | 2.84 | 7.29 | 1.89 | 1.52 | 7.49 | 8.51 | |
| P/TBV Ratio | - | - | 2.74 | 2.00 | 9.16 | 18.70 | |
| EV/Sales Ratio | - | - | - | - | - | 226.70 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.02 | |
| Asset Turnover | - | - | - | - | - | 0.04 | |
| Quick Ratio | 0.71 | 0.71 | 3.29 | 3.90 | 7.64 | 4.77 | |
| Current Ratio | 0.91 | 0.91 | 3.53 | 4.25 | 8.29 | 5.30 | |
| Return on Equity (ROE) | -136.66% | -136.66% | -101.88% | -156.34% | -120.39% | -88.61% | |
| Return on Assets (ROA) | -69.02% | -69.02% | -56.33% | -87.78% | -116.79% | -48.55% | |
| Return on Capital (ROIC) | -95.89% | -95.89% | -69.64% | -101.75% | -131.97% | -55.07% | |
| Earnings Yield | -102.85% | -42.70% | -62.82% | -123.19% | -13.64% | -8.21% | |
| FCF Yield | -81.52% | -33.84% | -49.78% | -86.24% | -13.97% | -6.44% | |
| Buyback Yield / Dilution | -11.84% | -11.84% | -36.37% | -21.50% | -40.32% | -87.63% | |
| Total Shareholder Return | -11.84% | -11.84% | -36.37% | -21.50% | -40.32% | -87.63% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.